학술논문
Guadecitabine (SGI-110) in patients with intermediate or high-risk myelodysplastic syndromes: phase 2 results from a multicentre, open-label, randomised, phase 1/2 trial
Document Type
Article
Author
Garcia-Manero, Guillermo; Roboz, Gail; Walsh, Katherine; Kantarjian, Hagop; Ritchie, Ellen; Kropf, Patricia; O'Connell, Casey; Tibes, Raoul; Lunin, Scott; Rosenblat, Todd; Yee, Karen; Stock, Wendy; Griffiths, Elizabeth; Mace, Joseph; Podoltsev, Nikolai; Berdeja, Jesus; Jabbour, Elias; Issa, Jean-Pierre J; Hao, Yong; Keer, Harold N; Azab, Mohammad; Savona, Michael R
Source
In The Lancet Haematology June 2019 6(6):e317-e327
Subject
Language
ISSN
2352-3026